4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Baijin Life Science Holdings Limited (1466) operates in the Luxury Goods industry and is headquartered in Wan Chai, Hong Kong with about 84 employees. Its market capitalization is roughly HK$2 billion. In the fiscal year ended 2026-03-31, 1466 reported HK$89M in revenue and (HK$38M) in net income.
Baijin Life Science Holdings Limited, together with its subsidiaries, engages in the procurement, processing, design, production, and wholesale distribution of pearls and fine jewelry products in Hong Kong, the People's Republic of China, the United States, and internationally.
Interactive charts & full statements → Open the 1466 valuation workbench →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | HK$89M | HK$136M | HK$54M | HK$87M | — |
| Gross Profit | HK$7M | HK$42M | HK$18M | HK$8M | — |
| Operating Income (EBIT) | (HK$47M) | HK$6M | (HK$10M) | HK$11M | — |
| Net Income | (HK$38M) | (HK$0M) | (HK$7M) | HK$9M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | HK$264M | HK$290M | HK$197M | HK$100M | — |
| Total Liabilities | HK$72M | HK$134M | HK$84M | HK$22M | — |
HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1466 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms